Identity. Mechanism. Evidence.
Complete profiles for every compound in the Veridyn Forma™ catalog. Additional profiles added as the catalog expands.
Body Protection Compound | Synthetic peptide derived from a protein naturally present in human gastric juice. 15 amino acids.
Mechanism: Upregulates growth hormone receptors in tendon fibroblasts, stimulates angiogenesis, modulates nitric oxide pathways, counteracts inflammatory overshoot. Accelerates progression through the tissue repair cascade.
Research: Substantial preclinical evidence across multiple tissue and injury types. Human clinical research ongoing and expanding.
Thymosin Beta-4 | Synthetic version of Thymosin Beta-4 — naturally present in virtually every cell in the human body.
Mechanism: Regulates actin polymerization enabling cell migration to injury sites, promotes cell survival at repair sites, reduces inflammation, supports angiogenesis. Systemic reach complements BPC-157's localized effects.
Research: Strong preclinical evidence. Documented effects on wound healing, tissue repair, and anti-inflammatory signaling.
GHRH Analog | Synthetic analog of Growth Hormone Releasing Hormone.
Mechanism: Binds to GHRH receptors on the pituitary, extends the growth hormone release pulse half-life, increases baseline IGF-1, preserves natural pulsatile GH release pattern.
Research: Well-established research in growth hormone secretagogue class. Clinical evidence for GH elevation and IGF-1 increase.
Selective GH Secretagogue | Synthetic growth hormone secretagogue acting on ghrelin receptors.
Mechanism: Selectively stimulates growth hormone release through ghrelin receptor pathway without significantly stimulating cortisol, prolactin, or appetite. Synergistic with CJC-1295.
Research: Strong research foundation. Notable for selectivity profile — cleaner GH signal than earlier secretagogue generations.
GHRH Analog (Established) | Synthetic GHRH analog with the longest established clinical record in this category.
Mechanism: Works through the same GHRH receptor pathway as CJC-1295 with shorter active window. Well-tolerated foundational protocol with extensive safety record.
Research: Most clinically established compound in the secretagogue category. History of use in pediatric growth disorders and age-related GH decline.
Semaglutide Analog | GLP-1 receptor agonist — analog of semaglutide.
Mechanism: Activates GLP-1 receptors triggering proportional insulin secretion, hypothalamic satiety signaling, gastric emptying modulation, glucagon suppression, and enhanced fat oxidation.
Research: FDA-recognized pharmacology class. Substantial clinical trial evidence for weight reduction, insulin sensitivity, and cardiovascular risk markers.
Tirzepatide Analog | Dual GIP and GLP-1 receptor agonist.
Mechanism: Activates both GIP and GLP-1 receptors simultaneously producing enhanced insulin sensitivity, more pronounced appetite reduction, and greater fat oxidation than single-pathway agonism.
Research: Compelling dual-agonist clinical data. Among the most robust metabolic outcome evidence in modern medicine.
Retatrutide Analog | Triple receptor agonist — GLP-1, GIP, and glucagon.
Mechanism: Adds glucagon receptor activation to the dual agonist profile — introducing direct thermogenic component increasing energy expenditure alongside appetite and insulin effects.
Research: Frontier metabolic pharmacology. Early clinical data among the most significant in metabolic research.
Synthetic Heptapeptide | Synthetic heptapeptide derived from ACTH. Originally developed in Russia for stroke recovery.
Mechanism: Upregulates BDNF, modulates dopaminergic and serotonergic systems, enhances cerebral blood flow, reduces neuroinflammation, improves HPA axis stress response. Produces BDNF elevation exceeding exercise alone.
Research: Substantial research foundation spanning neurological rehabilitation and cognitive optimization. Strong mechanistic evidence.
Pineal Tetrapeptide | Tetrapeptide derived from pineal peptide Epithalamin. Four decades of research.
Mechanism: Activates telomerase restoring telomere length, regulates epigenome toward youthful expression profiles, provides antioxidant activity, supports pineal gland function and circadian regulation.
Research: Longest-studied longevity peptide. Four decades of research. Strong mechanistic evidence for telomere effects.
Thymic Peptide | Naturally occurring thymic peptide. First isolated in the 1970s.
Mechanism: Promotes T cell maturation, enhances T helper cell function, stimulates natural killer cell activity, modulates inflammatory signaling, supports dendritic cell function, enhances vaccine response, demonstrates direct antiviral activity.
Research: Established clinical applications across 35+ countries. Used in hepatitis B, hepatitis C, and cancer treatment contexts. Decades of clinical evidence.
Bremelanotide | Synthetic melanocortin receptor agonist. Active compound in FDA-approved Vyleesi.
Mechanism: Activates MC3R and MC4R melanocortin receptors in the hypothalamic sexual response centers, stimulates dopamine release in desire pathways, produces neurological desire independent of hormonal status.
Research: FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Strong clinical evidence in both male and female populations.
Melanotan II | Synthetic analog of alpha-melanocyte stimulating hormone.
Mechanism: Activates full melanocortin receptor spectrum — MC1R for pigmentation, MC3R/MC4R for sexual function, MC5R for exocrine function. Produces spontaneous arousal, erectile support, skin tanning, and appetite modulation.
Research: Extensive research on melanocortin system activation. More pronounced arousal effect than PT-141. Dose titration important due to broader receptor profile.
Copper Peptide Complex | Naturally occurring human plasma peptide. Plasma concentration declines dramatically with age.
Mechanism: Stimulates fibroblast proliferation and collagen synthesis, promotes elastin and glycosaminoglycan production, regulates matrix metalloproteinases, provides antioxidant activity, stimulates angiogenesis, modulates inflammatory signaling, influences expression of 4000+ genes relevant to tissue repair.
Research: Five decades of research. Multiple clinical studies demonstrating collagen synthesis, skin thickness, and wound healing effects.